DOI: Published online: May 1, 2025 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea 2 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Jae Hyun Bae Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
FDA labeling includes a boxed warning regarding thyroid C-cell tumors based on rodent studies, though human relevance remains uncertain
The delivery route, absorption kinetics and tissue distribution differ fundamentally
Key Takeaways Semaglutide can start to show effects within the first week, with noticeable weight loss often seen within 4 to 5 months
2) Administration of the peptide BPC 157 enhances the expression of growth hormone receptors in tendon fibroblasts
Recovering Hidden Responder Groups in Individuals Receiving Neurofeedback for Tinnitus